AMIFOSTINE - Generic Drug Details

✉ Email this page to a colleague

What are the generic sources for amifostine and what is the scope of patent protection?

Amifostine is the generic ingredient in two branded drugs marketed by Eugia Pharma Speclts, Sun Pharm, and Clinigen, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for amifostine.

Summary for AMIFOSTINE

US Patents:	0
Tradenames:	2
Applicants:	3
NDAs:	3
Drug Master File Entries:	6
Raw Ingredient (Bulk) Api Vendors:	98
Clinical Trials:	86
Patent Applications:	7,405
Drug Prices:	Drug price trends for AMIFOSTINE
What excipients (inactive ingredients) are in AMIFOSTINE?	AMIFOSTINE excipients list
DailyMed Link:	AMIFOSTINE at DailyMed

See drug prices for AMIFOSTINE

Recent Clinical Trials for AMIFOSTINE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Institut du Cancer de Montpellier - Val d'Aurelle	Phase 3
Tata Memorial Centre	Phase 3
British Columbia Cancer Agency	Phase 2/Phase 3

See all AMIFOSTINE clinical trials

Medical Subject Heading (MeSH) Categories for AMIFOSTINE

Radiation-Protective Agents

Anatomical Therapeutic Chemical (ATC) Classes for AMIFOSTINE

V03AF	Detoxifying agents for antineoplastic treatment
V03A	ALL OTHER THERAPEUTIC PRODUCTS
V03	ALL OTHER THERAPEUTIC PRODUCTS
V	Various

Paragraph IV (Patent) Challenges for AMIFOSTINE

Tradename	Dosage	Ingredient	Strength	NDA	ANDAs Submitted	Submissiondate
ETHYOL	For Injection	amifostine	500 mg/vial	020221	1	2004-04-16

US Patents and Regulatory Information for AMIFOSTINE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Clinigen	ETHYOL	amifostine	INJECTABLE;INJECTION	020221-001	Dec 8, 1995		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Sun Pharm	AMIFOSTINE	amifostine	INJECTABLE;INJECTION	077126-001	Mar 14, 2008		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Clinigen	ETHYOL	amifostine	INJECTABLE;INJECTION	020221-002	Sep 10, 1999		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for AMIFOSTINE

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Clinigen	ETHYOL	amifostine	INJECTABLE;INJECTION	020221-002	Sep 10, 1999	⤷ Sign Up	⤷ Sign Up
Clinigen	ETHYOL	amifostine	INJECTABLE;INJECTION	020221-002	Sep 10, 1999	⤷ Sign Up	⤷ Sign Up
Clinigen	ETHYOL	amifostine	INJECTABLE;INJECTION	020221-001	Dec 8, 1995	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.